跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 927 条关于
“Cosmo N.V.”
全部
927
临床试验
428
药物
156
机构
183
资讯
160
4个月前
Cosmo Completes Phase II Enrollment for Novel Rifamycin Enema in Distal Ulcerative Colitis
去年
Cosmo Pharmaceuticals and Takeda Renew Multi-Year Manufacturing Agreement for Ulcerative Colitis Treatment
去年
Cosmo Pharmaceuticals Reports Progress in Clinical Trials and Strategic Growth in 2024
去年
Cosmo Pharmaceuticals Announces Strong 2024 Revenue Growth and Pipeline Advancements
去年
Cosmo Pharmaceuticals Launches First-in-Class Acne Treatment Winlevi in Southeast Asia
去年
European Regulators Approve First-in-Class Topical Anti-Androgen Therapy for Acne Treatment
去年
Rush University Medical Center Launches First-Ever Apple Vision Pro Colonoscopy Study with AI Integration
去年
Merus N.V. Advances in Oncology with Bizengri Approval and Promising Phase 2 Data for Petosemtamab
去年
Affimed N.V. Advances in Clinical Development of Novel Therapies for Solid and Liquid Tumors
9个月前
Cosmo's Clascoterone 5% Topical Solution Achieves Breakthrough Results in Phase III Male Pattern Hair Loss Trials
第 1 页,共 16 页
上一页
下一页